In a 2-year trial with semaglutide 0.5 mg and 1 mg once-weekly injection in adult patients with type 2 diabetes and high cardiovascular risk, diabetic retinopathy complications (which was a 4-component adjudicated endpoint) occurred in patients treated with semaglutide injection (3.0%) compared to placebo (1.8%)
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes (Phase 2 trial, Lancet 2023)
Peroxynitrite can initiate DNA damage, leading to the stimulation of a nuclear enzyme, poly (ADP-ribose) synthase (PARS), which causes a decrease in cellular energy levels and leads to cell death
These natural peptides run everything from energy production and tissue repair to inflammation control and hormone pulsing
Across the market as of April 2026, monthly totals generally fall between roughly $200 and $700+, with wide variance by compound and tier
& Slevin, J